Results 191 to 200 of about 2,327,860 (219)

Recombinant tissue plasminogen activators (rtPA): A review

Clinical Pharmacology & Therapeutics, 2015
P, Gurman, O R, Miranda, A, Nathan, C, Washington, Y, Rosen, N M, Elman   +5 more
openaire   +2 more sources

Recombinant tissue plasminogen activator: implications in therapy.

Seminars in hematology, 1989
Although the search for the ideal thrombolytic agent continues, recombinant tissue plasminogen activator (t-PA) has proven to be a more potent clot-specific thrombolytic agent than streptokinase. Because t-PA binds directly to the fibrin-plasminogen complex, its effect on circulating fibrinogen is minimized.
openaire   +1 more source

Recombinant tissue plasminogen activator

Reactions, 1986
openaire   +1 more source

Recombinant Tissue Plasminogen Activator

2011
openaire   +1 more source

Recombinant Tissue Plasminogen Activator

2012
openaire   +1 more source

Stability and Sterility of Recombinant Tissue Plasminogen Activator at −30°C

Lancet, The, 2000
Catherine M Clase, Mark Crowther, John T Wiernikowski   +2 more
exaly  

Coronary Thrombolysis with Recombinant Tissue Plasminogen Activator

Chest, 1991
Shian Gu, John Ducas, Kevin Wolfe, J Norman Patton, Richard M. Prewitt   +4 more
openaire   +1 more source

Randomised Trial of Intravenous Recombinant Tissue-Type Plasminogen Activator Versus Intravenous Streptokinase in Acute Myocardial Infarction: Report From the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator

Lancet, The, 1985
R Uebis, D Mathey, W Rutsch
exaly  

Complete Thrombolysis of Mesenteric Vein Occlusion With Recombinant Tissue-Type Plasminogen Activator.

Lancet, The, 1988
Yves Gruel
exaly  

Intravenous Administration of Recombinant Tissue Plasminogen Activator

Chest, 1995
Richard M. Prewitt, Shian Gu, Usha Schick, John Ducas   +3 more
openaire   +1 more source